FundedIQ
Biotechnology

Emulseo: Funding, Investors & Team (Oct 2026)

Emulseo is a new business focused on creating top-notch formulations for use in microfluidic applications. Our service is founded on extensive experience and knowledge in the field of microfluidics for the pharmaceutical, biotechnology, and chemical industries. Visit our website to learn more about the fluorinated surfactants, oils, surface treatments, and other goods we offer. We have a committed team of scientists focused on collaborating directly with you to create products and specialized solutions of the highest caliber and assist you with your projects, no matter what your application.

www.emulseo.com LinkedIn Pessac, France 11-50 employees
Total raised
$1.6M
Rounds
1
Latest
Seed
Nov 2022

Emulseo has raised $1.6M across 1 funding round on record, the most recent a Seed of $1.6M announced in Nov 2022.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Emulseo Company Profile and Key Stats

Total funding raised
$1.6M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$1.6M in Nov 2022
Employees
11-50
reported band
Headquarters
Pessac, France

Latest funding round on record: Nov 2022.

Emulseo Funding Rounds

Date
Round
Amount
Seed
$1.6M

Emulseo Founders and Leadership Team

Name
Role
Contact
Florine Maes
CEO
—

No contact details are on record for this team yet.

Emulseo Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
1,725
$7.0M
16,970
$3.1M

Emulseo's latest round of $1.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Emulseo in Biotechnology and Pessac

Companies Similar to Emulseo

Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…

Series A $12.6M

TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…

Series D $34.0M

NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…

Undisclosed round $6.9M

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…

Undisclosed round $1.7M

One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…

Undisclosed round —

Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…

Undisclosed round $120M

NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…

Undisclosed round $8.4M

AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…

Undisclosed round $11.6M

Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…

Undisclosed round $116M

Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…

Undisclosed round $7.0M

Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…

Undisclosed round $45.0M

AB Science was established in 2001 by a group of individuals in the medical and business fields who are…

Undisclosed round $3.7M

Emulseo Funding FAQs

What does Emulseo do?

Emulseo is a new business focused on creating top-notch formulations for use in microfluidic applications. Our service is founded on extensive experience and knowledge in the field of microfluidics for the pharmaceutical, biotechnology, and chemical industries. Visit our website to learn more about the fluorinated surfactants, oils, surface treatments, and other goods we offer. We have a committed team of scientists focused on collaborating directly with you to create products and specialized solutions of the highest caliber and assist you with your projects, no matter what your application.

How much funding has Emulseo raised?

Emulseo has raised $1.6M across 1 round on record. The most recent is a Seed of $1.6M announced in Nov 2022.

When did Emulseo last raise funding?

Emulseo's most recent funding round on record is a Seed of $1.6M, announced in Nov 2022.

Who is the CEO of Emulseo?

Florine Maes is listed as CEO at Emulseo.

Where is Emulseo headquartered?

Emulseo is based in Pessac, Aquitaine, France.

How many employees does Emulseo have?

Emulseo is in the 11-50 employee band.

How does Emulseo's funding compare to other Biotechnology startups?

Emulseo's latest round of $1.6M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Emulseo Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Emulseo is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.